Published in J Clin Invest on December 01, 1987
Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci (2002) 2.21
Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest (1989) 1.95
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89
Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer (1993) 1.68
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A (1994) 1.50
Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest (1992) 1.38
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36
Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest (1990) 1.28
Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J (1992) 1.27
92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest (1994) 1.26
Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest (1991) 1.23
92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol (1993) 1.18
Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J (2004) 1.15
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. Cancers (Basel) (2014) 1.10
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer (1995) 1.07
Human neutrophil gelatinase is a component of specific granules. J Clin Invest (1989) 1.04
Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol (1994) 1.01
Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One (2012) 0.98
Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activation. Cell Tissue Res (2009) 0.94
A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin Exp Immunol (2012) 0.94
Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma. Am J Pathol (1996) 0.90
Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice. Int J Exp Pathol (2000) 0.87
MMP 9 Gene Promoter Polymorphism in Gastric Cancer. Indian J Clin Biochem (2012) 0.79
Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling. Histochem Cell Biol (2012) 0.79
Decreased type V collagen expression in human decidual tissues of spontaneous abortion during early pregnancy. J Clin Pathol (1998) 0.79
Matrix metalloproteinase 9 is a distal-less 3 target-gene in placental trophoblast cells. Am J Physiol Cell Physiol (2013) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med (1971) 4.98
Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med (1975) 4.60
Secretion of a specific collagenase by stimulated macrophages. J Exp Med (1975) 4.56
Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem (1985) 3.51
Release of inflammatory mediators from stimulated neutrophils. N Engl J Med (1980) 3.35
A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15
Mouse macrophage elastase. Purification and characterization as a metalloproteinase. Biochem J (1981) 2.38
Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32
Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem (1986) 2.26
The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem (1981) 2.26
Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun (1982) 1.91
Physicochemical characterization and molecular organization of the collagen A and B chains. Biochemistry (1978) 1.80
Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J (1982) 1.66
The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J (1980) 1.64
Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem (1986) 1.62
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62
Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest (1985) 1.61
Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta (1985) 1.56
Secretory products of macrophages and their physiological functions. Am J Physiol (1984) 1.55
The collagen substrate specificity of human neutrophil collagenase. J Biol Chem (1987) 1.49
THE PRESENCE OF ORGANIC PHOSPHORUS IN COLLAGENS AND GELATINS. Biochim Biophys Acta (1964) 1.47
Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro. J Clin Invest (1979) 1.46
The structure of fibril-forming collagens. Ann N Y Acad Sci (1985) 1.34
Secreted forms of human neutrophil collagenase. J Biol Chem (1986) 1.31
Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures. J Exp Med (1983) 1.22
Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll Relat Res (1984) 1.11
Differentiation of a human leukemia cell line and expression of collagenase inhibitor. Proc Natl Acad Sci U S A (1985) 1.05
Secretion of collagenolytic enzymes by human polymorphonuclear leukocytes. Coll Relat Res (1984) 1.02
Heterogeneity among human collagenases demonstrated by monoclonal antibody that selectively recognizes and inhibits human neutrophil collagenase. J Exp Med (1984) 1.00
Collagen-platelet interaction. Type V(A-B) collagen induced platelet aggregation. J Lab Clin Med (1980) 0.91
The production of collagenase by adherent mononuclear cells cultured from human peripheral blood. Arthritis Rheum (1984) 0.88
A comparison of the binding and fate of internalized neutrophil elastase in human monocytes and alveolar macrophages. Am Rev Respir Dis (1983) 0.88
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med (1976) 3.17
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04
Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A (1978) 3.00
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest (1984) 2.88
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest (1976) 2.60
Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest (1988) 2.54
Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest (1979) 2.40
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med (1983) 2.28
Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine. Biochemistry (1972) 2.25
Collagen-induced arthritis, an animal model of autoimmunity. Life Sci (1997) 2.20
Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules. J Immunol (1984) 2.18
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Isolation of two distinct collagens from chick cartilage. Biochemistry (1970) 2.14
Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem (1980) 2.13
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci U S A (1982) 1.99
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem (1991) 1.96
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem (1988) 1.93
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood (1990) 1.71
Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest (1977) 1.68
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am Rev Respir Dis (1981) 1.64
Characterization of the alpha-chains of chick skin collagen and the nature of the NH2-terminal cross-link region. Biochemistry (1969) 1.63
Characterization of the cyanogen bromide peptides from the alpha 1 chain of chick skin collagen. Biochemistry (1969) 1.63
Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) (1984) 1.62
Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane. J Biol Chem (1982) 1.62
Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest (1989) 1.62
The nature and location of intramolecular cross-links in collagen. Proc Natl Acad Sci U S A (1966) 1.60
Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59
Studies on the structure of collagen utilizing a collagenolytic enzyme from tadpole. Biochemistry (1966) 1.59
Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med (1976) 1.57
Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin. FEBS Lett (2000) 1.57
The amino acid sequence of peptides from the cross-linking region of rat skin collagen. Biochemistry (1967) 1.54
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51
Collagen heterogeneity. High resolution separation of native ( 1(I) 2 2 and ( 1(II) 3 and their component chains. J Biol Chem (1972) 1.50
Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem (1980) 1.50
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1982) 1.47
Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J Infect Dis (1981) 1.46
Characterization of the cyanogen bromide peptides from the alpha-2 chain of chick skin collagen. Biochemistry (1969) 1.46
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
Dusts causing pneumoconiosis generate .OH and produce hemolysis by acting as Fenton catalysts. Arch Biochem Biophys (1989) 1.41
The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum (1990) 1.40
Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med (1989) 1.39
Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum (1984) 1.36
Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis (1982) 1.36
Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass. J Immunol Methods (1983) 1.36
Role of surface complexed iron in oxidant generation and lung inflammation induced by silicates. Am J Physiol (1992) 1.36
Human dipeptidyl-peptidase I. Gene characterization, localization, and expression. J Biol Chem (1997) 1.35
Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis (1983) 1.35
The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum (2000) 1.34
Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis (1981) 1.33
Secreted forms of human neutrophil collagenase. J Biol Chem (1986) 1.31
Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol (1998) 1.31
Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest (1985) 1.30
Copper-dependent inflammation and nuclear factor-kappaB activation by particulate air pollution. Am J Respir Cell Mol Biol (1998) 1.30
Animal collagenases: specificity of action, and structures of the substrate cleavage site. Biochem Biophys Res Commun (1974) 1.27
Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol (1998) 1.27
The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med (Berl) (1998) 1.26
Generation of a fibroblast chemotactic factor in serum by activation of complement. J Clin Invest (1979) 1.26
Collagen heterogeneity within different growth regions of long bones of rachitic and non-rachitic chicks. Biochem J (1972) 1.26
Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest (1992) 1.25
Transcriptional regulation of type I collagen genes in cultured fibroblasts by a factor isolated from thioacetamide-induced fibrotic rat liver. J Biol Chem (1984) 1.23
Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor. J Immunol (1976) 1.23
Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures. J Exp Med (1983) 1.22
Ectoprotein kinase activity of the isolated rat adipocyte. Biochem Biophys Res Commun (1979) 1.22
Pathogenesis of emphysema. Chest (1983) 1.22
Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21
Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages. Biochem Biophys Res Commun (1980) 1.21
A collagen defect in homocystinuria. J Clin Invest (1973) 1.20
Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet (1982) 1.20
Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. Am Rev Respir Dis (1982) 1.19
Lung fibrosis and emphysema: divergent responses to a common injury? Science (1982) 1.18
Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J Immunol (1994) 1.17
Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9 from type III collagen of human liver. Biochemistry (1981) 1.17
A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J Immunol (1989) 1.16
Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts. J Biol Chem (1986) 1.16
T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol (1993) 1.16
Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16
The in vitro formation of intermolecular cross-links in chick skin collagen. Biochem Biophys Res Commun (1970) 1.16